First Time Loading...

Beijing Hotgen Biotech Co Ltd
SSE:688068

Watchlist Manager
Beijing Hotgen Biotech Co Ltd Logo
Beijing Hotgen Biotech Co Ltd
SSE:688068
Watchlist
Price: 29.55 CNY -1.5% Market Closed
Updated: May 15, 2024
Beijing Hotgen Biotech Co Ltd
/
Income Statement
/
Income from Continuing Operations

Beijing Hotgen Biotech Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Beijing Hotgen Biotech Co Ltd
Income from Continuing Operations Peer Comparison

Comparables:
603259
300759
2269
300347
1548

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Beijing Hotgen Biotech Co Ltd
SSE:688068
Income from Continuing Operations
¥15.1m
CAGR 3-Years
-49%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Income from Continuing Operations
¥9.5B
CAGR 3-Years
31%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Income from Continuing Operations
¥1.4B
CAGR 3-Years
4%
CAGR 5-Years
33%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Income from Continuing Operations
¥3.6B
CAGR 3-Years
28%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Income from Continuing Operations
¥1.9B
CAGR 3-Years
-9%
CAGR 5-Years
28%
CAGR 10-Years
34%
Genscript Biotech Corp
HKEX:1548
Income from Continuing Operations
-$355.1m
CAGR 3-Years
-8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Beijing Hotgen Biotech Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
15.1m CNY

Based on the financial report for Dec 31, 2023, Beijing Hotgen Biotech Co Ltd's Income from Continuing Operations amounts to 15.1m CNY.

What is Beijing Hotgen Biotech Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-21%

Over the last year, the Income from Continuing Operations growth was -98%. The average annual Income from Continuing Operations growth rates for Beijing Hotgen Biotech Co Ltd have been -49% over the past three years , -21% over the past five years .

ALPHA SPREAD
Join more than 137,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.